Zymeworks (ZYME): Officer sold ~$382K
Scott Platshon, Officer at Zymeworks, sold ~$382K of Zymeworks shares.
- ~$382K
- Approx. value · 15K sh @ $24.95
- 22K
- Holds after · shares reported
- Traded
- Nov 18, 2026
- Filed
- Nov 18, 2026
What stands out in this filing
- The sale was 41.3% of the shares this insider held before it; the filing reports 21,745 shares afterwards.
- 15,292 shares at an average of $24.95 each, as reported on the form.
- Footnote references tax withholding.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 23, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement (and 2 more items)“On September 23, 2026, Zymeworks issued a press release announcing the closing of the Merger. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.”
- Oct 9, 2026InsiderOfficer sold ~$358K of ZYME shares in the open market
- Oct 22, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
- Nov 9, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Nov 13, 2026Insider · 1 personInsiders: 3 sales (~$1.0M)
- Nov 18, 2026 · this disclosureInsiderOfficer sold ~$382K of ZYME shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Zymeworks
For Zymeworks, OQRO holds 8 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ZYME page.
How this filing works
Explore the data
Common questions
Which Zymeworks (ZYME) insider traded, and how much?
Scott Platshon, Officer at Zymeworks, sold ~$382K of Zymeworks shares. 15K shares at $24.95.
When did it happen, and when was it made public?
Traded: Nov 18, 2026. Filed: Nov 18, 2026.
What stands out in this filing?
The sale was 41.3% of the shares this insider held before it; the filing reports 21,745 shares afterwards. 15,292 shares at an average of $24.95 each, as reported on the form. Footnote references tax withholding.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Zymeworks recently?
For Zymeworks, OQRO holds 8 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ZYME page.
Does this mean ZYME stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Zymeworks
- SEC Form 144Nov 18, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 144Nov 13, 2026
- SEC Form 144Oct 9, 2026
Everything OQRO holds on this company is on its ZYME page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
